Long Term Daily Use of JARDIANCE® Tablets in Japanese Patients With Type 2 Diabetes Mellitus

Efficacy and Safety Study of Empagliflozin as add-on to Insulin in Japanese Patients With Type 2 Diabetes Mellitus

NCT02589639 ·Status: COMPLETED ·Phase: PHASE4

Trial to Evaluate the Efficacy and Safety of Dapagliflozin in Japanese Type 2 Diabetes Mellitus Patients

NCT00972244 ·Status: COMPLETED ·Phase: PHASE2

A Study of the Glucodynamic Effects of Dulaglutide (LY2189265) in Japanese Participants With Type 2 Diabetes

NCT03315780 ·Status: COMPLETED ·Phase: PHASE4

Phase IV Study With a 36-week Extension Period to Evaluate the Efficacy and Safety of Dapagliflozin Therapy When Added to the Therapy of Japanese Patients With Type 2 Diabetes With Inadequate Glycemic Control on Insulin.

NCT02157298 ·Status: COMPLETED ·Phase: PHASE4

Efficacy and Safety of Exenatide in Japanese Patients With Type 2 Diabetes Who Are Treated With Oral Antidiabetic(s)

NCT00577824 ·Status: COMPLETED ·Phase: PHASE3

The Safety and Efficacy of Dapagliflozin Therapy in Combination With Insulin in Japanese Subjects With T1DM

NCT02582814 ·Status: COMPLETED ·Phase: PHASE3

A Study to Assess the Effect on Glucose Control and Safety and Tolerability of LY2148568 In Japanese Patients With Type 2 Diabetes

NCT00382239 ·Status: COMPLETED ·Phase: PHASE2

Clinical Assessment of GSK716155 for Type 2 Diabetes Mellitus

NCT00530309 ·Status: COMPLETED ·Phase: PHASE1

A Study of Dulaglutide in Japanese Participants With Type 2 Diabetes

NCT02750410 ·Status: COMPLETED ·Phase: PHASE4

Empagliflozin Add on to Linagliptin Study in Japanese Patient With Type 2 Diabetes Mellitus

NCT02453555 ·Status: COMPLETED ·Phase: PHASE3

A Study of LY3502970 in Japanese Participants With Type 2 Diabetes Mellitus

NCT05086445 ·Status: COMPLETED ·Phase: PHASE1

A Study of Two Doses of Dulaglutide (LY2189265) in Japanese Patients With Type 2 Diabetes

NCT04809220 ·Status: COMPLETED ·Phase: PHASE3

A Long-term Study on the Side Effects of TRADIANCE in Japanese Patients With Type 2 Diabetes

NCT03761797 ·Status: COMPLETED

Long-term Daily Use of Trazenta® Tablets in Patients With Type 2 Diabetes Mellitus

NCT01650259 ·Status: COMPLETED

A Phase 1 Study In Japanese Subjects With Type 2 Diabetes Mellitus As Monotherapy

NCT02292433 ·Status: COMPLETED ·Phase: PHASE1

BI 1356 BS in Japanese Patients With Type 2 Diabetes Mellitus

NCT02183324 ·Status: COMPLETED ·Phase: PHASE2

Linagliptin as Add on Therapy to Empagliflozin 10 mg or 25 mg With Japanese Patients With Type 2 Diabetes Mellitus

NCT02489968 ·Status: COMPLETED ·Phase: PHASE3

A Long-term Safety Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes

NCT03861039 ·Status: COMPLETED ·Phase: PHASE3

Safety and Tolerability Study of MEDI0382 in Japanese Preobese or Obese Subjects With Type 2 Diabetes

NCT03645421 ·Status: COMPLETED ·Phase: PHASE2

To Evaluate the Efficacy and Safety of JT-003 add-on in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and Dapagliflozin

NCT05296044 ·Status: UNKNOWN ·Phase: PHASE3

A Monotherapy Study to Evaluate the Efficacy and Safety of 2 Dose Levels of Albiglutide in Japanese Subjects With Type 2 Diabetes Mellitus (T2DM)

NCT01733758 ·Status: COMPLETED ·Phase: PHASE3

Safety and Tolerability of Lixisenatide in Combination With Oral Anti-Diabetic Treatment in Patients With Type 2 Diabetes

NCT01940965 ·Status: COMPLETED ·Phase: PHASE3

A Single-Dose Study of MK6349 in Patients With Type 2 Diabetes (6349-002)

NCT00943371 ·Status: TERMINATED ·Phase: PHASE1

A Study of LY3549492 in Participants With Type 2 Diabetes Mellitus (T2DM)

NCT05327595 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety of BI 1356 (Linagliptin) Versus Placebo in Type 2 Diabetic Patients With Insufficient Glycemic Control

NCT00621140 ·Status: COMPLETED ·Phase: PHASE3